跳至主要内容
临床试验/EUCTR2011-003158-24-FI
EUCTR2011-003158-24-FI进行中(未招募)不适用

A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer patients in Finland - RAXO

Pia Österlund and Helena Isoniemi0 个研究点目标入组 1,000 人开始时间: 2011年9月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • 1.Patients with histologically confirmed CRC, who are scheduled to start or are getting first line chemotherapy for metastatic disease
  • 2.Age > 18
  • 3.Metastatic disease (including locally advanced disease not amenable with surgery and/or (chemo)radiotherapy)
  • 4.Signed written informed consent according to ICH/GCP and the local regulations (approved by the Independent Ethics Committee [IEC]) will be obtained prior to study
  • 5.No informed consent will be obtained from patients participating in the data collection study obtaining data from hospital charts without blood sampling and contacting of patients
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
Pia Österlund and Helena Isoniemi

相似试验

A population-based prospective study to evaluate... | 临床试验